How best to express oestrogen receptor activity

European Journal of Cancer

Volumn 36, Issue SUPPL. 4, 2000, Pages 21-23

  Hawkins, R A ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Biochemical assay; Cut off; ER; Immunocytochemical assay; Quantitation; Response

Indexed keywords

ESTROGEN RECEPTOR;

ARTICLE; BREAST CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECEPTOR DENSITY;

EID: 0033765970     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(00)00210-0     Document Type: Article

References (6)

1. Prospective evaluation of prognostic factors in operable breast cancer
2. Oestrogen receptors, lactate dehydrogenase and cellularity in human breast cancer
3. Clinical interpretation of receptor measurements
4. Tamoxifen increases apoptosis but does not influence markers of proliferation in an MCF-7 xenograft model of breast cancer
5. Therapeutic significance of sex-steroid hormone receptors in the treatment of breast cancer
6. Detection of the oestrogen receptor (ER): Immunohistochemical versus cytosol measurements